Response to commentary re: Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's oncology group

      Pediatric and adolescent patients with testicular germ cell tumors (TGCT) are a particularly challenging population to study given the relatively uncommon incidence of TGCT in children. Unlike in adults, there are no reliable prognostic features to individualize risk of relapse among children with low-stage TGCT. Given this pressing clinical need, herein we leveraged data from three prospective cooperative trials to identify clinicopathologic features predictive for relapse in children with stage I TGCT.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Linked Article